TrialMax®:

Consumer-Grade UX.
Clinical-Grade Everything Else.

The patient experience in TrialMax has been redesigned for modern devices and modern expectations, without changing the validated solution underneath.

DISCUSS YOUR PROTOCOL

Where Lasting Impressions Begin

Patients interact with TrialMax regularly, often daily, often on their own device, in their own home, without support on hand. For many, this interface is their most frequent point of contact with the study itself, and it shapes their impression of the trial as a whole.

Older patients, first-time app users, and anyone completing an assessment during a difficult moment all benefit from an interface that is easy to read, with intuitive navigation and clear direction to tasks like logging a diary entry or preparing for an upcoming clinic visit.

Modern, By Design

Driving Engagement

A patient interface built this way keeps patients engaged with the study throughout its duration. A screen that asks less of the patient in the moment, less effort to read, navigate, and understand, means fewer missed entries and fewer support calls. The underlying solution is unchanged, so sites continue working exactly as they do today, and sponsors retain the full configuration, complexity, and protocol flexibility TrialMax studies depend on.

Section-4-image-1

Same TrialMax.
New Front End.

The result is a patient experience built to modern standards, on the same TrialMax platform sites already know.

Section-1-image-1

 

Let's discuss your protocol

Frequently Asked Questions

Does this change how patient data is captured or validated?
No. The redesign changes how the interface looks and feels. The rules that govern how each assessment is presented, scored, captured, stored, and transmitted are unchanged.
Does the new interface work across devices and browsers?
Yes. It's built to work on modern mobile and desktop devices, with a standard web fallback included.
What accessibility standards does the redesigned UI meet?
The interface follows international touch-target (WCAG 2.1) and contrast (WCAG 2.1 AA) standards, and supports both light and dark display modes for patients with light sensitivity or visual impairment.

WHO IS SIGNANT HEALTH


Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. Learn more at www.signanthealth.com.